Well Health Technologies Stock Price To Earning
| WELL Stock | CAD 5.86 0.31 5.59% |
WELL Health Technologies fundamentals help investors to digest information that contributes to WELL Health's financial success or failures. It also enables traders to predict the movement of WELL Stock. The fundamental analysis module provides a way to measure WELL Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to WELL Health stock.
WELL | Price To Earning |
WELL Health Technologies Company Price To Earning Analysis
WELL Health's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
WELL Price To Earning Driver Correlations
Understanding the fundamental principles of building solid financial models for WELL Health is extremely important. It helps to project a fair market value of WELL Stock properly, considering its historical fundamentals such as Price To Earning. Since WELL Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of WELL Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of WELL Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
WELL Retained Earnings
Based on the latest financial disclosure, WELL Health Technologies has a Price To Earning of 0.0 times. This is 100.0% lower than that of the Health Care Providers & Services sector and about the same as Health Care (which currently averages 0.0) industry. The price to earning for all Canada stocks is 100.0% higher than that of the company.
WELL Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of WELL Health from analyzing WELL Health's financial statements. These drivers represent accounts that assess WELL Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of WELL Health's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 151.2M | 1.1B | 937.3M | 626.8M | 910.7M | 956.2M | |
| Enterprise Value | 154.7M | 1.0B | 1.3B | 936.3M | 1.3B | 1.4B |
WELL Fundamentals
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0245 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 1.79 B | ||||
| Shares Outstanding | 248.93 M | ||||
| Shares Owned By Insiders | 21.32 % | ||||
| Shares Owned By Institutions | 6.12 % | ||||
| Number Of Shares Shorted | 1.29 M | ||||
| Price To Book | 1.72 X | ||||
| Price To Sales | 1.52 X | ||||
| Revenue | 776.05 M | ||||
| Gross Profit | 303.29 M | ||||
| EBITDA | 101.88 M | ||||
| Net Income | 82 K | ||||
| Cash And Equivalents | 48.91 M | ||||
| Cash Per Share | 0.25 X | ||||
| Total Debt | 426.28 M | ||||
| Debt To Equity | 0.48 % | ||||
| Current Ratio | 1.14 X | ||||
| Book Value Per Share | 3.40 X | ||||
| Cash Flow From Operations | 62.59 M | ||||
| Short Ratio | 1.25 X | ||||
| Earnings Per Share | 0.31 X | ||||
| Price To Earnings To Growth | (1.32) X | ||||
| Target Price | 7.68 | ||||
| Beta | 1.18 | ||||
| Market Capitalization | 1.46 B | ||||
| Total Asset | 1.41 B | ||||
| Retained Earnings | (63.58 M) | ||||
| Working Capital | 23.44 M | ||||
| Net Asset | 1.41 B |
About WELL Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze WELL Health Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of WELL Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of WELL Health Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in WELL Stock
WELL Health financial ratios help investors to determine whether WELL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in WELL with respect to the benefits of owning WELL Health security.